FDA Issues Myocarditis Warning for Non-mRNA Novavax COVID-19 Shot

In its review of the Novavax COVID-19 shot, the FDA issued a warning about the risk of myocarditis for the non-mRNA injection. The company is seeking FDA¬†emergency use authorization for the shot, positioning it both as a booster for the vaccinated and an alternative first shot for those who rejected the mRNA jabs. But Novavax … Continue reading FDA Issues Myocarditis Warning for Non-mRNA Novavax COVID-19 Shot